The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Racial Disparities Result in Unprecedented Differences in Outcomes for SLE Patients

Racial Disparities Result in Unprecedented Differences in Outcomes for SLE Patients

October 13, 2015 • By Eric L. Wise, MD, & W. Joseph McCune, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Although the advent of the MMF era has brought forth important gains for black patients in particular, many questions remain unanswered. Will advances in our understanding of genetics lead to the identification of new genetic contributors to severe lupus? Recent studies suggest that alleles of APOL1 that are commonly found in individuals of African heritage may be strong predictors of ESRD from lupus nephritis.12 Similarly, early evidence suggests that there may be a genetic contribution to the rates of MMF metabolism that may predispose black patients to a lack of response to MMF therapy. Can we glean new knowledge about the role of socioeconomic and environmental factors that contribute to worsening lupus?

You Might Also Like
  • Infection Rates for Patients with SLE on Immunosuppressive Drugs
  • Cardiovascular Disease Rate Differs Between SLE Patients of Different Races, Ethnicities
  • Racial Disparities in Rheumatology: What Are We Doing About It?
Explore This Issue
October 2015

These differences may now be more apparent, given our greater understanding of the racial differences in response to therapy. The issues of access and adherence to therapy strategies remain poorly addressed topics. Can we improve access to, and delivery of, care by adapting strategies developed in the fight against HIV for lupus patients?

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

As we enter the era of personalized medicine, we will ultimately have to develop approaches that account for the various genetic, social and environmental factors and are tailored to the needs of the individual patient.


Eric L. Wise, MD, is a rheumatologist in Ann Arbor, Mich.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

W. Joseph McCune, MD, is a rheumatologist at the University of Michigan, in Ann Arbor, Mich., and was recognized as a Master by the ACR in 2014.

References

  1. Chakravarty EF, Bush TM, Manzi S, et al. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: Estimates obtained using hospitalization data. Arthritis Rheum. 2007 Jun;56(6):2092–2094.
  2. Fessel WJ. Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med. 1974 Dec;134(6):1027–1035.
  3. Kaslow RA, Masi AT. Age, sex, and race effects on mortality from systemic lupus erythematosus in the United States. Arthritis Rheum. 1978 May;21(4):473–479.
  4. Ward MM. Changes in the incidence of endstage renal disease due to lupus nephritis in the United States, 1996–2004. J Rheumatol. 2009 Jan;36(1):63–67.
  5. Austin HA 3rd, Boumpas DT, Vaughan EM, et al. High-risk features of lupus nephritis: Importance of race and clinical and histological factors in 166 patients. Nephrol Dial Transplant. 1995;10(9):1620–1628.
  6. Cooper GS, Parks CG, Treadwell EL, et al. Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the Southeastern United States. Lupus. 2002;11(3):161–167.
  7. Alarcon GS, Calvo-Alén J, McGwin G Jr., et al. Systemic lupus erythematosus in a multiethnic cohort: LUMINA XXXV. Predictive factors of high disease activity over time. Ann Rheum Dis. 2006 Sep;65(9):1168–1174.
  8. Reveille JD, Moulds JM, Ahn C, et al. Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture. Arthritis Rheum. 1998 Jul;41(7):1161–1172.
  9. Barr RG, Seliger S, Appel GB, et al. Prognosis in proliferative lupus nephritis: The role of socio-economic status and race/ethnicity. Nephrol Dial Transplant. 2003 Oct;18(10):2039–2046.
  10. Richman IB, Taylor KE, Chung SA, et al. European genetic ancestry is associated with a decreased risk of lupus nephritis. Arthritis Rheum. 2012 Oct;64(10):3374–3382.
  11. Isenberg D, Appel GB, Contreras G, et al. Influence of race/ethnicity on response to lupus nephritis treatment: The ALMS study. Rheumatology (Oxford). 2010 Jan;49(1):128–140.
  12. Freedman BI, Langefeld CD, Andringa KK, et al. End-stage renal disease in African Americans with lupus nephritis is associated with APOL1. Arthritis Rheumatol. 2014 Feb;66(2):390–396.

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions, SLE (Lupus) Tagged With: Clinical, Lupus, Outcomes, racial disparities, SLE, Systemic lupus erythematosusIssue: October 2015

You Might Also Like:
  • Infection Rates for Patients with SLE on Immunosuppressive Drugs
  • Cardiovascular Disease Rate Differs Between SLE Patients of Different Races, Ethnicities
  • Racial Disparities in Rheumatology: What Are We Doing About It?
  • New Studies Examine Impact of Poverty, Race, Ethnicity in Patients with SLE

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)